top of page

Pamorelin Powder for Suspension for Injection 11.25 mg per vial

Product details

Registration number: SIN14324P

Classification: Prescription Only

Active ingredients: Triptorelin Embonate 16.8 mg eqv Triptorelin

Strength: 11.25 mg

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Route: INTRAMUSCULAR

Registrant: ORIENT EUROPHARMA PTE LTD

ATC code: L02AE04

HSA approval date: 11 March 2013

Manufacturer(s):

  • Debiopharm Research & Manufacturing SA
  • Synergy Health Daniken AG (Contract Sterilization Facility)

Manufacturing country/countries: SWITZERLAND

What are the HSA registration number and classification for Pamorelin Powder for Suspension for Injection 11.25 mg per vial?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14324P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Pamorelin Powder for Suspension for Injection 11.25 mg per vial?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Triptorelin Embonate 16.8 mg eqv Triptorelin

Strength: 11.25 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Pamorelin Powder for Suspension for Injection 11.25 mg per vial?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for Pamorelin Powder for Suspension for Injection 11.25 mg per vial?

According to the HSA dataset updated 7 August 2026:

Registrant: ORIENT EUROPHARMA PTE LTD

Source for this answer

Which manufacturers and countries are listed for Pamorelin Powder for Suspension for Injection 11.25 mg per vial?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Debiopharm Research & Manufacturing SA
  • Synergy Health Daniken AG (Contract Sterilization Facility)

Manufacturing country/countries: SWITZERLAND

Source for this answer

Where can I look up Pamorelin Powder for Suspension for Injection 11.25 mg per vial in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14324P or the exact product name Pamorelin Powder for Suspension for Injection 11.25 mg per vial. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Pamorelin Powder for Suspension for Injection 11.25 mg per vial record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Pamorelin Powder for Suspension for Injection 11.25 mg per vial record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14324P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page